Tech Company M&A Transactions
NeoMend Acquisition
NeoMend, operating out of Irvine, was acquired by C.R. Bard. C.R. Bard said the transaction price was $165 million.
Transaction Overview
Company Name
Acquired By
Announced On
10/24/2012
Transaction Type
M&A
Amount
$165,000,000
M&A Terms
The merger consideration is for a purchase price of $140 million paid at closing and future contingent payments up to an additional $25 million based on specific revenue-based milestones through 2016.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
60 Technology Drive
Irvine, CA 92618
USA
Irvine, CA 92618
USA
Phone
Website
Email Address
Overview
NeoMend, Inc. is a privately held, clinical stage biomedical device company engaged in the development and commercialization of advanced surgical wound healing products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Renzi
Chief Financial Officer
Kevin Cousins
VP - Marketing
Mike Nagel
VP - Operations
David Hanson
VP - R & D
Peter Davis
VP - Regulatory Affairs
Pamela Misajon
Browse more venture capital transactions:
Prev: 10/24/2012: Airbnb venture capital transaction
Next: 10/24/2012: Mirna Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC transactions reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs